Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by MEDA PHARMS
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
000793
BUTISOL SODIUM
New Drug Application
Approval
006530
AVC
New Drug Application
Approval
011792
SOMA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
012365
SOMA COMPOUND
New Drug Application
Approval
New combination
(S) Standard review drug
012366
SOMA COMPOUND W/ CODEINE
New Drug Application
Approval
New combination
(S) Standard review drug
016848
ANADROL-50
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017351
CORTIFOAM
New Drug Application
Approval
New formulation
(S) Standard review drug
018307
THYRO-BLOCK
New Drug Application
Approval
018677
CESAMET
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
018983
COLYTE
COLYTE WITH FLAVOR PACKS
COLYTE-FLAVORED
New Drug Application
Approval
New combination
(S) Standard review drug
019618
ROWASA
SFROWASA
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
019715
DIPENTUM
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
019854
DEPEN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019919
ROWASA
New Drug Application
Approval
New formulation
(S) Standard review drug
020114
ASTELIN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
020136
DEMADEX
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
020189
FELBATOL
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
020479
GASTROCROM
New Drug Application
Approval
New formulation
(S) Standard review drug
020700
MUSE
New Drug Application
Approval
New formulation
(P) Priority review drug
021127
OPTIVAR
New Drug Application
Approval
New formulation
(S) Standard review drug
021247
AEROSPAN HFA
New Drug Application
Approval
New formulation
(S) Standard review drug
021793
REGLAN ODT
New Drug Application
Approval
New formulation
(S) Standard review drug
021813
ELESTRIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
021997
EDLUAR
New Drug Application
Approval
New formulation
022203
ASTEPRO
New Drug Application
Approval
New manufacturer
(S) Standard review drug
076491
TRILYTE
Abbreviated New Drug Application
Approval
084566
LUFYLLIN
Abbreviated New Drug Application
Approval
085380
BUTISOL SODIUM
Abbreviated New Drug Application
Approval
086195
PROCTOFOAM HC
Abbreviated New Drug Application
Approval
086457
EPIFOAM
Abbreviated New Drug Application
Approval
202236
DYMISTA
New Drug Application
Approval
New combination
(S) Standard review drug
Back to Companies who have applied for FDA Drug Approval